Chronic endometritis

disease
On this page

Also known as endometritis, chronic

Summary

Chronic endometritis (MONDO:0024279) is a disease and 12 clinical trials. Top therapeutic interventions include 17. A subtype of endometritis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 12

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namechronic endometritis
Mondo IDMONDO:0024279
ICD-11440849195
NCITC102820
SNOMED CT63922003
UMLSC0238104
MedGen536766
Is cancer (heuristic)no

Also known as: chronic endometritis · endometritis, chronic

Disease family

This is a subtype of endometritis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorderfemale reproductive system disorderuterine disorderendometrial disorderendometritischronic endometritis

Related subtypes (2): acute endometritis, endomyometritis

Subtypes (2): non specific chronic endometritis, granulomatous endometritis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 12.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified7
PHASE1/PHASE22
PHASE22
PHASE41

Top trials by phase / activity

NCTPhaseStatusTitle
NCT07485842PHASE4NOT_YET_RECRUITINGFuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis
NCT07180563PHASE1/PHASE2RECRUITINGRandomized Controlled Trial of Berberine in Combination With Doxycycline in the Treatment of Chronic Endometritis
NCT04432467PHASE1/PHASE2COMPLETEDFertility Restoration Using Autologous Mesenchymal Stem Cells
NCT04447625PHASE2COMPLETEDIntrauterine Antibiotic Infusion in Treating Chronic Endometritis and Restoring Reproductive Dynamics
NCT05205993PHASE2UNKNOWNΕffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic Endometritis
NCT07488949Not specifiedRECRUITINGDoxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF)
NCT02646930Not specifiedCOMPLETEDChronic Endometritis and IVF
NCT02648698Not specifiedCOMPLETEDRCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis
NCT02680275Not specifiedCOMPLETEDEfficacy of Dead Sea Peloid Gel in Chronic Endometritis
NCT02744807Not specifiedCOMPLETEDRole of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Adhesions
NCT03169621Not specifiedTERMINATEDDiagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive Treatments
NCT06890754Not specifiedCOMPLETEDHysteroscopy for Chronic Endometritis: Diagnostic Performance and Observer Variability

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
1701

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.